Macrophage-mediated IL-6 signaling drives ryanodine receptor–2 calcium leak in postoperative atrial fibrillation
Postoperative atrial fibrillation (poAF) is AF occurring days after surgery, with a prevalence of 33% among patients undergoing open-heart surgery. The degree of postoperative inflammation correlates with poAF risk, but less is known about the cellular and molecular mechanisms driving postoperative atrial arrhythmogenesis. We performed single-cell RNA-seq comparing atrial nonmyocytes from mice with and without poAF, which revealed infiltrating CCR2+ macrophages to be the most altered cell type. Pseudotime trajectory analyses identified Il-6 as a gene of interest driving in macrophages, which we confirmed in pericardial fluid collected from human patients after cardiac surgery. Indeed, macrophage depletion and macrophage-specific Il6ra conditional knockout (cKO) prevented poAF in mice. Downstream STAT3 inhibition with TTI-101 and cardiomyocyte-specific Stat3 cKO rescued poAF, indicating a proarrhythmogenic role of STAT3 in poAF development. Confocal imaging in isolated atrial cardiomyocytes (ACMs) uncovered what we believe to be a novel link between STAT3 and CaMKII-mediated ryanodine receptor-2 (RyR2)-Ser(S)2814 phosphorylation. Indeed, nonphosphorylatable RyR2S2814A mice were protected from poAF, and CaMKII inhibition prevented arrhythmogenic Ca2+ mishandling in ACMs from mice with poAF. Altogether, we provide multiomic, biochemical, and functional evidence from mice and humans that IL-6-STAT3-CaMKII signaling driven by infiltrating atrial macrophages is a pivotal driver of poAF, which portends therapeutic utility for poAF prevention.
Authors
- Xander H.T. Wehrens (ORCID: https://orcid.org/0000-0001-5044-672X)
- Li Na
- Irene M. Ong (ORCID: https://orcid.org/0000-0002-9353-6941)
- Ying H. Shen (ORCID: https://orcid.org/0000-0003-4119-115X)
- Mihail G. Chelu (ORCID: https://orcid.org/0000-0001-9688-1604)
- Dobromir Dobrev (ORCID: https://orcid.org/0000-0002-4612-117X)
- Florian Bruns (ORCID: https://orcid.org/0000-0001-6269-5061)
- Markus Kamler (ORCID: https://orcid.org/0000-0001-6608-8496)
- Marcel Tekook
- José Alberto Navarro‐García (ORCID: https://orcid.org/0000-0002-0317-4888)
- A Paasche (ORCID: https://orcid.org/0000-0001-6882-1428)
- Yuriana Aguilar-Sánchez (ORCID: https://orcid.org/0000-0002-5516-8877)
- Luge Li
- Joshua A. Keefe (ORCID: https://orcid.org/0000-0002-6209-6488)
- Issam Abu-Taha (ORCID: https://orcid.org/0000-0002-2298-8959)
- Shuai Zhao (ORCID: https://orcid.org/0009-0007-0006-8987)
Institutions
- Baylor College of Medicine (US)
- Heidelberg University (DE)
- Montreal Heart Institute (CA)
- University Hospital Heidelberg (DE)
- St. Luke's Hospital (US)
- Cardiovascular Institute Hospital (JP)
- Essex Cardiothoracic Centre (GB)
- Essen University Hospital (DE)
- Pediatrics and Genetics (US)
- West German Heart and Vascular Center Essen (DE)
- University of Duisburg-Essen (DE)
- Université de Montréal (CA)
Publication Details
- Journal
- Journal of Clinical Investigation
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1172/jci187711
- Citations
- 14
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 19.43
Funders
- European Commission
- National Institutes of Health